# US 2025/0082826 A1 · Compressed Collagen Composite Construct for Cell or Therapeutic Delivery

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0082826 A1
- Document ID: US20250082826A1
- Status: Published application
- Kind: A1
- Application number: 18/727,159
- Filed: 2023-01-27
- Published: 2025-03-13
- Earliest claimed: 2022-01-28
- Assignees: The Board of Trustees of the Leland Stanford Junior University
- Applicants: The Board of Trustees of the Leland Stanford Junior University
- Inventors: Yunzhi Yang; Seyedsina Moeinzadeh; Geoffrey Abrams
- Web page: https://patentgrep.com/patent/US20250082826A1

## CPC

- A61K 9/0024: {Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue (compositions for intravenous administration, normal injectable solutions or dispersions for, e.g. subcutaneous administration A61K9/0019; brain implants A61K9/0085; (coated) prostheses, catheters or stents A61L)}
- A61L 27/48: with macromolecular fillers
- A61K 47/42: Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein (oligopeptides having up to five amino acids {A61K47/183}; polyamino acids A61K47/34)
- A61L 27/24: Collagen
- A61L 27/52: Hydrogels or hydrocolloids
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- A61L 27/56: Porous materials, {e.g. foams or sponges}
- A61K 35/00: Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K 38/00: Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00)
- A61K 47/34: Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers (A61K47/10 takes precedence)
- A61L 2400/18: Modification of implant surfaces in order to improve biocompatibility, cell growth, fixation of biomolecules, e.g. plasma treatment
- A61L 2430/24: for joint reconstruction
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)

## Abstract

Technology is provided for the production of collagen-based composite grafts with robust mechanical properties exceeding that of typical collagen hydrogels or foams. Collagen is a biodegradable and biocompatible hydrogel, but its clinical application is limited by poor mechanical properties that hinders its manipulation during surgeries and its post-surgical stability. The new collagen composite construct has robust mechanical properties for easy surgical handling such as rolling, suturing and passing a small surgical port during arthroscopic procedure, while maintaining unique biological characteristics of collagen matrix. Cells from various sources, bone marrow aspirate concentrates, growth factors, nanoparticles/microparticles (NPs/MPs), and supportive polymer meshes can be incorporated into the membranes for drug delivery and tissue regenerative therapies.

## Claims

### Claim 1

A method of making a therapeutic collagen-based delivery platform, comprising:
(a) having a mesh of struts of polymers;
(b) treating a surface of the mesh of struts of polymers to form a hydrophilic surface followed by coating with interactive molecular onto the surface of the mesh of struts for polymers to physically attach to the surface to enhance interaction with collagen, and wherein the treated mesh has a thickness of 0.2 to 3 mm;
(c) embedding the treated mesh in a collagen hydrogel forming a composite construct, wherein the collagen in the collagen hydrogel physically attaches to the polymers of the treated surface, wherein the collagen hydrogel has a thickness of 4 to 20 mm larger, and wherein the collagen hydrogel is loaded with therapeutics; and
(d) compressing the collagen hydrogel such that the composite construct has a thickness of 0.2 to 3 mm, plus not more than 300, 400, 600 or 900 micrometers.

### Claim 2 (depends on 1)

The method as set forth in claim 1, further comprising freeze-drying the composite construct.

### Claim 3 (depends on 1)

The method as set forth in claim 1, further comprising coating the composite construct.

### Claim 4 (depends on 1)

The method as set forth in claim 1, further comprising embedding the composite construct in a sponge.

### Claim 5 (depends on 1)

The method as set forth in claim 1, wherein the therapeutics are cells, drugs, proteins, peptides, small molecules, RNA, or particles loaded with drugs, proteins, small molecules, peptides, or RNA.

### Claim 6 (depends on 1)

The method as set forth in claim 1, wherein the therapeutic collagen-based delivery platform produced by the method is used for regeneration or repair of an orthopedic injury or a soft tissue injury.

### Claim 7 (depends on 1)

The method as set forth in claim 1, wherein the therapeutic collagen-based delivery platform produced by the method is used for regeneration or repair of a rotator cuff repair.

### Claim 8

A therapeutic collagen-based delivery platform for regeneration or repair of an orthopedic injury or a soft tissue injury, comprising: a therapeutic collagen-based delivery platform, wherein the platform comprises a mesh of polymer struts having a hydrophilic surface and interactive surface molecules, wherein the mesh of polymer struts is embedded in a compressed collagen hydrogel, wherein the collagen in the collagen hydrogel is physically attached to polymers at the mesh surface through interactive molecules, wherein the thickness of the mesh of polymer struts is only increased by up to 300, 400, 600 or 900 micrometers as a result of the embedded and compressed collagen hydrogel.
